BEIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy systems, today announced that it will participate in Credit Suisse's 2007 Asian Technology Conference - China Day.
Location: Shenzhen, China
Date: September 10, 2007
China Medical Technologies' management team will discuss the Company's strategy, operations and growth opportunities, as well as its published results to date with securities analysts and institutional portfolio managers.
Please contact Credit Suisse for more information about the conference.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using Enhanced Chemiluminescence (ECLIA) technology and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound (HIFU) for the treatment of solid cancers and benign tumors. For more information, please visit http://www.chinameditech.com .
For more information, please contact:
China Medical Technologies, Inc.
Winnie Fan
Tel: +86-10-6530-8833
Email: IR@chinameditech.com
